Halocortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H27ClF2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z9TL048W82, chemically known as 9-chloro-6alpha,11beta-difluoro-21-hydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as halocortolone, which bears US NIH Compound Identifier 214342. European Medicines Agency schedules Halocortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07997MIG. The term HALOCORTOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). HALOCORTOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halocortolone under HS 29372200 and SITC 54153. As of Q4 2014, HALOCORTOLONE remains the US FDA Preferred Term for this commodity. Halocortolone bears US NLM identifiers UMLS ID C2828224 and NCI Concept Code C87232. SMILES: CLC12C(C3C(C(C(C3)C)C(=O)CO)(CC1F)C)CC(F)C1=CC(=O)C=CC21C.